Literature DB >> 16804985

Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.

Wei Liu1, Zai-Cheng Yu, Wen-Feng Cao, Fang Ding, Zhi-Hua Liu.   

Abstract

AIM: To investigate the role of transglutaminase 3 (TGM3) gene in human esophageal squamous cell carcinoma (ESCC), and analyze its relationship with clinicopathological parameters.
METHODS: Gene expression of TGM3 in fresh esophageal cancer tissues and their corresponding normal mucosas was detected immunohistochemically (IHC) by means of tissue microarray (TMA). Its correlation with clinical characteristics was evaluated and analyzed by univariate analysis. All statistical analyses were performed by SPSS version 10.0.
RESULTS: Expression rate of TGM3 was reduced to 81.8% in ESCC. Expression of TGM3 was significantly inversely correlated with histological grade of esophageal carcinoma (in grade I, II and III tumors, the reduced expression was 4/7, 57/71, and 20/21, respectively, P < 0.05), whereas it had no obvious correlations with lymph node metastasis and depth of invasion.
CONCLUSION: Reduced expression of TGM3 may play an important role in esophageal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16804985      PMCID: PMC4087948          DOI: 10.3748/wjg.v12.i24.3929

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Beta-catenin expression is altered in human colonic aberrant crypt foci.

Authors:  X P Hao; T G Pretlow; J S Rao; T P Pretlow
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

2.  Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67.

Authors:  Wafaey Gomaa; Youqiang Ke; Hiroshi Fujii; Timothy Helliwell
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

3.  Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z.

Authors:  P Grenard; M K Bates; D Aeschlimann
Journal:  J Biol Chem       Date:  2001-06-04       Impact factor: 5.157

4.  Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China.

Authors:  W Zhang; J E Bailey-Wilson; W Li; X Wang; C Zhang; X Mao; Z Liu; C Zhou; M Wu
Journal:  Am J Hum Genet       Date:  2000-06-06       Impact factor: 11.025

5.  [Study on the loss of heterozygosity and expression of transglutaminase 3 gene in laryngeal carcinoma].

Authors:  Guang He; Zhen Zhao; Weineng Fu; Xinghe Sun; Zhenming Xu; Kailai Sun
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2002-04

6.  Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma.

Authors:  Ying-Cheng Lin; Ming-Yao Wu; De-Rui Li; Xian-Ying Wu; Rui-Ming Zheng
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

7.  Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma.

Authors:  Hernan E Gonzalez; Manu Gujrati; Mitchell Frederick; Ying Henderson; Jayakumar Arumugam; Paul W Spring; Kenji Mitsudo; Hyung-Woo Kim; Gary L Clayman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-07

8.  Retinoic acid-induced transglutaminase in mouse epidermal cells is distinct from epidermal transglutaminase.

Authors:  U Lichti; T Ben; S H Yuspa
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

9.  Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray.

Authors:  Aiping Luo; Jianping Kong; Gengxi Hu; Choong-Chin Liew; Momiao Xiong; Xiuqin Wang; Junfang Ji; Tao Wang; Huiying Zhi; Min Wu; Zhihua Liu
Journal:  Oncogene       Date:  2004-02-12       Impact factor: 9.867

10.  Structural basis for the coordinated regulation of transglutaminase 3 by guanine nucleotides and calcium/magnesium.

Authors:  Bijan Ahvazi; Karen M Boeshans; William Idler; Ulrich Baxa; Peter M Steinert; Fraydoon Rastinejad
Journal:  J Biol Chem       Date:  2003-11-28       Impact factor: 5.157

View more
  6 in total

1.  Positional cloning and next-generation sequencing identified a TGM6 mutation in a large Chinese pedigree with acute myeloid leukaemia.

Authors:  Li-Li Pan; Yuan-mao Huang; Min Wang; Xiao-e Zhuang; Dong-feng Luo; Shi-cheng Guo; Zhi-shun Zhang; Qing Huang; Sheng-long Lin; Shao-yuan Wang
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

2.  Examination of oral cancer biomarkers by tissue microarray analysis.

Authors:  Peter Choi; C Diana Jordan; Eduardo Mendez; John Houck; Bevan Yueh; D Gregory Farwell; Neal Futran; Chu Chen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-05

3.  Methylation of TGM-3 Promoter and Its Association with Oral Squamous Cell Carcinoma (OSCC).

Authors:  Sorour Shojaeian; Abdolkarim Moazeni-Roodi; Abdolamir Allameh; Ata Garajei; Anoshirvan Kazemnejad; Kourosh Kabir; Amir-Hassan Zarnani
Journal:  Avicenna J Med Biotechnol       Date:  2021 Apr-Jun

4.  Combination of meta-analysis and graph clustering to identify prognostic markers of ESCC.

Authors:  Hongyun Gao; Lishan Wang; Shitao Cui; Mingsong Wang
Journal:  Genet Mol Biol       Date:  2012-06-23       Impact factor: 1.771

5.  Validation of tissue microarray technology in squamous cell carcinoma of the esophagus.

Authors:  Judith Boone; Richard van Hillegersberg; Paul J van Diest; G Johan A Offerhaus; Inne H M Borel Rinkes; Fiebo J W Ten Kate
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

6.  TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer.

Authors:  Xiangbing Wu; Wei Cao; Xu Wang; Jianjun Zhang; Zhongjing Lv; Xing Qin; Yadi Wu; Wantao Chen
Journal:  Mol Cancer       Date:  2013-12-01       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.